Research and development

Continually innovating to push the boundaries of human advancement in medicine

We are committed to investing broadly in innovation and development of best-in-class or first-in-class products and supporting technologies. Our current focus is within oncology and infectious diseases, but we are also exploring opportunities in novel therapeutic areas such as autoimmune disorders.

Technology platform

Our core technology is the Vaccibody™ platform, based on the concept of targeting antigen to Antigen Presenting Cells to create better vaccines.

Therapeutic areas

Our technology platform may benefit the lives of patients across several areas of high unmet need. Our pipeline is currently focused on cancer and infectious diseases, and we have initiated research within autoimmune disorders

Scientific papers and presentations

See our latest scientific papers and presentations here

Scientific papers and presentations